Key stats
Market capitalization
5.708BUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
6.85
Basic EPS (TTM)
12.57USD
About QuidelOrtho Corporation
ISIN
US2197981051
Sector
Health Technology
Industry
Medical Specialties
Website
quidelortho.com
CEO
Douglas C. Bryant
Headquarters
San Diego
Employees
7K
Founded
2022
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
Revenue